|
|
|
|
|
By Bilel Khedir, Galien Pharmaceuticals | This is the first published application of data envelopment analysis to six major pharmaceutical analytical validation guidelines, including ICH Q2(R2), USP, ChP, and Brazil's ANVISA. | |
|
|
|
By David Elder, ELIQUENT Life Sciences | Are you ready? FDA has begun to implement the use of artificial intelligence in its operations, particularly during inspection activities. | |
|
|
|
A conversation with Joshua Nelson of Takeda and Life Science Connect's Jon O'Connell | Additive manufacturing in early-phase process development is growing more common, but the practice comes with important considerations. | |
|
|
|
A conversation between Gillian Buckley, Ph.D., of PhRMA and Life Science Connect's Jon O'Connell | Credibility and trustworthiness in AI models are related but distinct attributes. If you're using them in GMP manufacturing, you should understand the difference. | |
|
|
|
|
